Albendazole
- Product NDC
- 0115-1701
- 11-digit product format
- 001151701
- Labeler code
- 0115
- Product ID
- 0115-1701_2da2a777-2835-429d-b73a-31b8e0bde571
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- albendazole
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Application
- NDA020666
- Marketing category
- NDA
- Marketing start
- 1996-06-11
- Substance
- ALBENDAZOLE
- Active strength
- 200 mg/1
- Pharmacologic classes
- Anthelmintic [EPC], Cytochrome P450 1A Inducers [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Albendazole
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| ALBENDAZOLE | 200 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | F4216019LN |
| Rxcui | 199672 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 0115-1701-49 | Albendazole | 2 in 1 BOTTLE | TABLET, FILM COATED | 2 | | 9 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 0115-1701 | ALBENDAZOLE TABLET, FILM COATED [AMNEAL PHARMACEUTICALS OF NEW YORK LLC] | 9 | Current NDC, Legacy NDC, 1 package rows | 20240102_06b5eefc-0b95-4862-b9b6-770063f2adf0.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0115-1701-49 | 00115170149 | 2 TABLET, FILM COATED in 1 BOTTLE (0115-1701-49) | 1996-06-11 | 0000-00-00 | No | No | Current |